Moderna: Why I Am Selling The 'Relief Rally' [Seeking Alpha]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Seeking Alpha
MRNA's recent rally is driven by improved liquidity, cost discipline, and a $1.5 billion non-dilutive loan, not core business growth. Discontinuing the CMV program removes a key pipeline pillar, increasing dependence on declining COVID and underperforming RSV franchises. MRNA's strategy focuses on survival via cost cuts and cash runway extension, sacrificing long-term pipeline value and growth visibility, in my opinion. Edwin Tan/E+ via Getty Images Introduction Moderna, Inc.'s stock ( MRNA ) has rallied ~23% since my last Sell rating in August. Although I acknowledged the long-term potential of its CMV and personalized cancer vaccines, the company was burning $2-3 billion per year This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiv
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna, Inc. (MRNA): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- HFA Architecture + Engineering Taps Sherwood Butler as Vice President [Yahoo! Finance]Yahoo! Finance
- Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Morgan Stanley.MarketBeat
- Moderna (NASDAQ:MRNA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating on the stock.MarketBeat
MRNA
Earnings
- 11/6/25 - Beat
MRNA
Sec Filings
- 12/16/25 - Form SC
- 12/15/25 - Form 4
- 12/15/25 - Form 4
- MRNA's page on the SEC website